Clinical Trial Update: Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting safety and tolerability data for phenylbutyrate in Inclusion Body Myositis, with the study status shown as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inclusion Body Myositis
• Sporadic Inclusion Body Myositis

Drugs mentioned

• Phenylbutyrate (phenylbutyrate)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Inclusion Body Myositis, Sporadic Inclusion Body Myositis | Phase 1 | Status: COMPLETED